The pharmaceutical field is experiencing a important shift in blood sugar treatment with the arrival of GLP-1 transdermal devices. These revolutionary delivery systems offer a potentially easy choice to needle injections for individuals dealing with type 2 diabetes. By circumventing the requirement for frequent pokes, GLP-1 skin devices promise to